Praxis Precision Medicines (PRAX) Retained Earnings (2020 - 2026)

Praxis Precision Medicines' Retained Earnings history runs 7 years deep, the most recent figure standing at -$1.6 million for Q1 2026.

• In Q1 2026, Retained Earnings fell 100.12% year-over-year to -$1.6 million; the TTM figure through Mar 2026 stood at -$1.6 million (down 100.12% YoY), while the FY2025 annual figure was $563000.0, down 13.91% from the prior year.
• Retained Earnings for Q1 2026 stood at -$1.6 million, down from $563000.0 in the prior quarter.
• The five-year high for Retained Earnings was $1.3 billion in Q1 2025, with the low at -$1.1 billion in Q3 2025.
• The 5-year median for Retained Earnings is -$515500.0 (2025), against an average of -$13.4 million.
• Peak annual rise in Retained Earnings reached 293.89% in 2025, while the deepest fall reached 79070.47% in 2025.
• Praxis Precision Medicines' Retained Earnings stood at $606.9 million in 2022, then increased by 19.22% to $723.6 million in 2023, then sank by 99.91% to $654000.0 in 2024, then dropped by 13.91% to $563000.0 in 2025, then slumped by 383.13% to -$1.6 million in 2026.
• Business Quant data shows PRAX's Retained Earnings at -$1.6 million in Q1 2026, $563000.0 in Q4 2025, and -$1.1 billion in Q3 2025.